ReP USP - Resultado da busca

Artigo de periodico
Relationship between SLCO1B(3) and ABCA(3) polymorphisms and imatinib response in chronic myeloid leukemia patients (2015)
Lima, Luciene Terezina de; Bueno, Carolina Tosin; Vivona, Douglas; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Hungria, Vania Tietsche de Moraes; Chiattone, Carlos Sérgio; Zanichelli, Maria Aparecida; Chauffaille, Maria de Lourdes Lopes Ferrari; Guerra-Shinohara, Elvira Maria
Source: Hematology. Unidade: FCF
Subjects: LEUCEMIA MIELOIDE, FARMACOGENÉTICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Luciene Terezina de et al. Relationship between SLCO1B(3) and ABCA(3) polymorphisms and imatinib response in chronic myeloid leukemia patients. Hematology, v. 20, n. 3, p. 137-142, 2015Tradução . . Disponível em: https://doi.org/10.1179/1607845414Y.0000000181. Acesso em: 31 out. 2024.
APA
Lima, L. T. de, Bueno, C. T., Vivona, D., Hirata, R. D. C., Hirata, M. H., Hungria, V. T. de M., et al. (2015). Relationship between SLCO1B(3) and ABCA(3) polymorphisms and imatinib response in chronic myeloid leukemia patients. Hematology, 20( 3), 137-142. doi:10.1179/1607845414Y.0000000181
NLM
Lima LT de, Bueno CT, Vivona D, Hirata RDC, Hirata MH, Hungria VT de M, Chiattone CS, Zanichelli MA, Chauffaille M de LLF, Guerra-Shinohara EM. Relationship between SLCO1B(3) and ABCA(3) polymorphisms and imatinib response in chronic myeloid leukemia patients [Internet]. Hematology. 2015 ; 20( 3): 137-142.[citado 2024 out. 31 ] Available from: https://doi.org/10.1179/1607845414Y.0000000181
Vancouver
Lima LT de, Bueno CT, Vivona D, Hirata RDC, Hirata MH, Hungria VT de M, Chiattone CS, Zanichelli MA, Chauffaille M de LLF, Guerra-Shinohara EM. Relationship between SLCO1B(3) and ABCA(3) polymorphisms and imatinib response in chronic myeloid leukemia patients [Internet]. Hematology. 2015 ; 20( 3): 137-142.[citado 2024 out. 31 ] Available from: https://doi.org/10.1179/1607845414Y.0000000181
Artigo de periodico
Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia (2014)
Lima, Luciene Terezinha de; Vivona, Douglas; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Castro, Fabíola Attié de; Chauffaille, Maria de Lourdes L. F; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Hungria, Vania Tietsche de Moraes; Guerra-Shinohara, Elvira Maria
Source: Medical Oncology. Unidades: FCF, FCFRP
Subjects: LEUCEMIA MIELOIDE, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Luciene Terezinha de et al. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical Oncology, v. 31, p. 1-11, 2014Tradução . . Disponível em: https://doi.org/10.1007/s12032-014-0851-5. Acesso em: 31 out. 2024.
APA
Lima, L. T. de, Vivona, D., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2014). Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia. Medical Oncology, 31, 1-11. doi:10.1007/s12032-014-0851-5
NLM
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Castro FA de, Chauffaille M de LLF, Zanichelli MA, Chiattone CS, Hungria VT de M, Guerra-Shinohara EM. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia [Internet]. Medical Oncology. 2014 ; 31 1-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12032-014-0851-5
Vancouver
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Castro FA de, Chauffaille M de LLF, Zanichelli MA, Chiattone CS, Hungria VT de M, Guerra-Shinohara EM. Reduced ABCG2 and increased SLC22A1 mRNA expression are associated with imatinib response in chronic myeloid leukemia [Internet]. Medical Oncology. 2014 ; 31 1-11.[citado 2024 out. 31 ] Available from: https://doi.org/10.1007/s12032-014-0851-5
Trabalho de evento-resumo
Polymorphisms in ABC transporter genes are associated with complete molecular response to imatinib in chronic myeloid leukemia patients (2012)
Vivona, Douglas; Lima, Luciene Terezinha de; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Source: Abstracts. Conference titles: Congress of the European Hematology Association. Unidade: FCF
Subjects: LEUCEMIA MIELOIDE, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. Polymorphisms in ABC transporter genes are associated with complete molecular response to imatinib in chronic myeloid leukemia patients. 2012, Anais.. The Hague: European Hematology Association, 2012. . Acesso em: 31 out. 2024.
APA
Vivona, D., Lima, L. T. de, Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2012). Polymorphisms in ABC transporter genes are associated with complete molecular response to imatinib in chronic myeloid leukemia patients. In Abstracts. The Hague: European Hematology Association.
NLM
Vivona D, Lima LT de, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Polymorphisms in ABC transporter genes are associated with complete molecular response to imatinib in chronic myeloid leukemia patients. Abstracts. 2012 ;[citado 2024 out. 31 ]
Vancouver
Vivona D, Lima LT de, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Polymorphisms in ABC transporter genes are associated with complete molecular response to imatinib in chronic myeloid leukemia patients. Abstracts. 2012 ;[citado 2024 out. 31 ]
Artigo de periodico
ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib (2012)
Vivona, Douglas; Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Source: Blood Cells, Molecules, and Diseases. Unidade: FCF
Subjects: LEUCEMIA MIELOIDE AGUDA, POLIMORFISMO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Blood Cells, Molecules, and Diseases, v. 48, n. 2, p. 132-136, 2012Tradução . . Disponível em: https://doi.org/10.1016/j.bcmd.2011.11.001. Acesso em: 31 out. 2024.
APA
Vivona, D., Bueno, C. T., Lima, L. T. de, Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2012). ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Blood Cells, Molecules, and Diseases, 48( 2), 132-136. doi:10.1016/j.bcmd.2011.11.001
NLM
Vivona D, Bueno CT, Lima LT de, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib [Internet]. Blood Cells, Molecules, and Diseases. 2012 ; 48( 2): 132-136.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.bcmd.2011.11.001
Vancouver
Vivona D, Bueno CT, Lima LT de, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. ABCB1 haplotype is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib [Internet]. Blood Cells, Molecules, and Diseases. 2012 ; 48( 2): 132-136.[citado 2024 out. 31 ] Available from: https://doi.org/10.1016/j.bcmd.2011.11.001
Trabalho de evento-resumo
SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients (2011)
Guerra-Shinohara, Elvira Maria ; Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Vivona, Douglas; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Chiattone, Carlos Sérgio; Zanichelli, Maria Aparecida
Source: Abstracts. Conference titles: Annual Congress of the European Hematology Association (EHA). Unidade: FCF
Subjects: POLIMORFISMO, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA-SHINOHARA, Elvira Maria et al. SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. 2011, Anais.. Hague: European Hematology Association (EHA), 2011. . Acesso em: 31 out. 2024.
APA
Guerra-Shinohara, E. M., Bueno, C. T., Lima, L. T. de, Vivona, D., Hirata, R. D. C., Hirata, M. H., et al. (2011). SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. In Abstracts. Hague: European Hematology Association (EHA).
NLM
Guerra-Shinohara EM, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Luchessi AD, Chiattone CS, Zanichelli MA. SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. Abstracts. 2011 ;[citado 2024 out. 31 ]
Vancouver
Guerra-Shinohara EM, Bueno CT, Lima LT de, Vivona D, Hirata RDC, Hirata MH, Luchessi AD, Chiattone CS, Zanichelli MA. SLC22A1 polymorphisms are not associated with cytogenetic and molecular response to imatinib mesylate in chronic myelogenous leukemia patients. Abstracts. 2011 ;[citado 2024 out. 31 ]
Trabalho de evento-resumo
Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib (2011)
Guerra-Shinohara, Elvira Maria ; Vivona, Douglas; Bueno, Carolina Tosin; Lima, Luciene Terezinha de; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio
Source: Abstracts. Conference titles: Annual Congress of the European Hematology Association (EHA). Unidade: FCF
Subjects: POLIMORFISMO, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
GUERRA-SHINOHARA, Elvira Maria et al. Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. 2011, Anais.. Hague: European Hematology Association (EHA), 2011. . Acesso em: 31 out. 2024.
APA
Guerra-Shinohara, E. M., Vivona, D., Bueno, C. T., Lima, L. T. de, Hirata, R. D. C., Hirata, M. H., et al. (2011). Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. In Abstracts. Hague: European Hematology Association (EHA).
NLM
Guerra-Shinohara EM, Vivona D, Bueno CT, Lima LT de, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS. Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Abstracts. 2011 ;[citado 2024 out. 31 ]
Vancouver
Guerra-Shinohara EM, Vivona D, Bueno CT, Lima LT de, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS. Haplotype for polymorphisms C1236T, C3435T and C2677T/A in MDR1 gene is associated with major molecular response in chronic myeloid leukemia patients treated with standard-dose of imatinib. Abstracts. 2011 ;[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia (2011)
Lima, L. T; Vivona, Douglas; Bueno, C. T; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Source: Revista Brasileira de Hematologia e Hemoterapia. Conference titles: Congresso Brasileiro de Hematologia e Hemoterapia. Unidade: FCF
Subjects: LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, L. T et al. Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2011
APA
Lima, L. T., Vivona, D., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2011). Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Lima LT, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. 2011 ; 33 144-145 res. 0340.[citado 2024 out. 31 ]
Vancouver
Lima LT, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Imatinib response is influenced by ABCG2 and SLC22A1 gene expression in chronic myeloid leukemia. Revista Brasileira de Hematologia e Hemoterapia. 2011 ; 33 144-145 res. 0340.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate (2011)
Lima, Luciene Terezinha de; Vivona, Douglas; Bueno, Carolina Tosin; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Chiattone, Carlos Sérgio; Zanichelli, Maria Aparecida; Guerra-Shinohara, Elvira Maria
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidade: FCF
Subjects: LEUCEMIA MIELOIDE AGUDA, EXPRESSÃO GÊNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
LIMA, Luciene Terezinha de et al. ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2011
APA
Lima, L. T. de, Vivona, D., Bueno, C. T., Hirata, R. D. C., Hirata, M. H., Chiattone, C. S., et al. (2011). ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Chiattone CS, Zanichelli MA, Guerra-Shinohara EM. ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 66 res. FCF128.[citado 2024 out. 31 ]
Vancouver
Lima LT de, Vivona D, Bueno CT, Hirata RDC, Hirata MH, Chiattone CS, Zanichelli MA, Guerra-Shinohara EM. ABCG2 gene expression in chronic myeloid Leukemia patients treate with imatinib Mesylate. Brazilian Journal of Pharmaceutical Sciences. 2011 ; 47 66 res. FCF128.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
Association between the C1236T, C3435T and G2677T/A polymorphisms in the ABCB1 gene and response markers for imatinib mesylate in patients with chronic myeloid leukemia (2010)
Bueno, Carolina Tosin; Vivona, Douglas; Lima, Luciene Terezinha de; Hirata, Mario Hiroyuki ; Hirata, Rosario Dominguez Crespo ; Luchessi, André Ducati; Chiattone, Carlos Sérgio; Zanichelli, Maria Aparecida; Guerra-Shinohara, Elvira Maria
Source: Brazilian Journal of Pharmaceutical Sciences. Conference titles: Science and Pharmaceutical Technology Meeting of the Pharmaceutical Sciences Faculty of the University of São Paulo. Unidade: FCF
Subjects: POLIMORFISMO, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
BUENO, Carolina Tosin et al. Association between the C1236T, C3435T and G2677T/A polymorphisms in the ABCB1 gene and response markers for imatinib mesylate in patients with chronic myeloid leukemia. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2010
APA
Bueno, C. T., Vivona, D., Lima, L. T. de, Hirata, M. H., Hirata, R. D. C., Luchessi, A. D., et al. (2010). Association between the C1236T, C3435T and G2677T/A polymorphisms in the ABCB1 gene and response markers for imatinib mesylate in patients with chronic myeloid leukemia. Brazilian Journal of Pharmaceutical Sciences. São Paulo: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Bueno CT, Vivona D, Lima LT de, Hirata MH, Hirata RDC, Luchessi AD, Chiattone CS, Zanichelli MA, Guerra-Shinohara EM. Association between the C1236T, C3435T and G2677T/A polymorphisms in the ABCB1 gene and response markers for imatinib mesylate in patients with chronic myeloid leukemia. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 85 res. FCF165.[citado 2024 out. 31 ]
Vancouver
Bueno CT, Vivona D, Lima LT de, Hirata MH, Hirata RDC, Luchessi AD, Chiattone CS, Zanichelli MA, Guerra-Shinohara EM. Association between the C1236T, C3435T and G2677T/A polymorphisms in the ABCB1 gene and response markers for imatinib mesylate in patients with chronic myeloid leukemia. Brazilian Journal of Pharmaceutical Sciences. 2010 ; 46 85 res. FCF165.[citado 2024 out. 31 ]
Trabalho de evento-resumo periodico
Associação entre os polimorfismos C1236T, C3435T e G2677T/A no gene ABCB1 e marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica (2010)
Vivona, Douglas; Bueno, C. T; Lima, L. T; Hirata, Rosario Dominguez Crespo ; Hirata, Mario Hiroyuki ; Luchessi, André Ducati; Zanichelli, Maria Aparecida; Chiattone, Carlos Sérgio; Guerra-Shinohara, Elvira Maria
Source: Revista Brasileira de Hematologia e Hemoterapia. Conference titles: Congresso Brasileiro de Hematologia Pediátrica. Unidade: FCF
Subjects: POLIMORFISMO, LEUCEMIA MIELOIDE
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIVONA, Douglas et al. Associação entre os polimorfismos C1236T, C3435T e G2677T/A no gene ABCB1 e marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo. . Acesso em: 31 out. 2024. , 2010
APA
Vivona, D., Bueno, C. T., Lima, L. T., Hirata, R. D. C., Hirata, M. H., Luchessi, A. D., et al. (2010). Associação entre os polimorfismos C1236T, C3435T e G2677T/A no gene ABCB1 e marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica. Revista Brasileira de Hematologia e Hemoterapia. Rio de Janeiro: Faculdade de Ciências Farmacêuticas, Universidade de São Paulo.
NLM
Vivona D, Bueno CT, Lima LT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Associação entre os polimorfismos C1236T, C3435T e G2677T/A no gene ABCB1 e marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica. Revista Brasileira de Hematologia e Hemoterapia. 2010 ; 32 137 res. 0349.[citado 2024 out. 31 ]
Vancouver
Vivona D, Bueno CT, Lima LT, Hirata RDC, Hirata MH, Luchessi AD, Zanichelli MA, Chiattone CS, Guerra-Shinohara EM. Associação entre os polimorfismos C1236T, C3435T e G2677T/A no gene ABCB1 e marcadores de resposta ao mesilato de imatinibe em pacientes com leucemia mieloide crônica. Revista Brasileira de Hematologia e Hemoterapia. 2010 ; 32 137 res. 0349.[citado 2024 out. 31 ]

USP Schools

ReP

Filtros

Authors

Source title

Conference titles

Non normalized affiliation